Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Type I diabetes mellitus | R-HSA-5683209 | map04940 | vancomycin | 5510 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | tenoxicam | 54677971 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | tenoxicam | 54677971 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tenoxicam | 54677971 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tenoxicam | 54677971 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tenoxicam | 54677971 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | tenoxicam | 54677971 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | piracetam | 4843 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | piracetam | 4843 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | piracetam | 4843 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | piracetam | 4843 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | piracetam | 4843 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | piracetam | 4843 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | etamsylate | 3828 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | etamsylate | 3828 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | etamsylate | 3828 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | etamsylate | 3828 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | etamsylate | 3828 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | etamsylate | 3828 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | etamsylate | 3828 | drug-path |